euro adhoc: Sanacorp Pharmahandel AG / Justice/Processes / Sanacorp Pharmahandel AG reaches agreement on termination of avoidance action

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

Spin-offs

22.10.2007

Sanacorp Pharmahandel AG and the shareholders who brought an action
against Sanacorp Pharmahandel AG to set aside the resolutions passed
at the Annual General Meeting held on June 27, 2007 (see ad hoc
statement of August 21, 2007, 11:36:00 AM) have agreed today to end
the dispute by way of a settlement in court.

The parties to the settlement - along with the four plaintiffs and
Sanacorp Pharmahandel AG, this is also Sanacorp eG Pharmazeutische
Großhandlung, which will join the action for the purpose of
settlement - have agreed that a one-time special dividend of EUR 0.35
for each preference share be distributed in fiscal year 2008 to all
preference shareholders of the defendant. This is to be a
compensation for any disadvantages which the plaintiffs allege to
suffer from the business combination of the pharmaceutical
wholesaling companies Sanacorp Pharmahandel AG and Coopérative
d´Exploitation et de Répartition Pharmaceutiques de Rouen S.A.,
Rouen, France (CERP Rouen). There will be no compensation to the sole
ordinary shareholder Sanacorp eG Pharmazeutischen Großhandlung.

For this purpose, Sanacorp eG Pharmazeutische Großhandlung undertakes
towards the plaintiffs and all other preference shareholders of
Sanacorp Pharmahandel AG to agree on a change of the Articles of
Incorporation on the occasion of the next annual general meeting of
Sanacorp Pharmahandel AG, enabling the above-stated special dividend.
If the statutory requirements are met, i.e. if there is sufficient
net retained profit in particular, the special dividend will be
approved in the Annual General Meeting of Sanacorp Pharmahandel AG in
2009 and paid out then.

In addition, Sanacorp Pharmahandel AG has accepted the duty to keep
the plaintiffs and the other preference shareholders informed.

The plaintiffs, in turn, will withdraw the action brought against
Sanacorp Pharmahandel AG to set aside the resolutions passed at the
Annual General Meeting held on June 27, 2007 in relation to the items
5, 7 and 8 of the agenda. Sanacorp Pharmahandel AG will bear the cost
of the litigation and the settlement.

To become effective, the settlement requires a declaration by the
court. Details of the settlement, if it is reached upon the advice
and request of the responsible court and if matching pleadings of all
parties involved are filed, will be published in the newspapers
authorized to publish company announcements.

Planegg, October 22, 2007

Sanacorp Pharmahandel Aktiengesellschaft
The Management Board

end of announcement euro adhoc 22.10.2007 17:15:00
--------------------------------------------------------------------------------

ots Originaltext: Sanacorp Pharmahandel AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Dr Thomas Strieder
Telefon: +49(089) 8581 494
E-Mail: ir@sanacorp.de

Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / official dealing